Analyst Price Target is $18.75
▲ +271.29% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Curaleaf in the last 3 months. The average price target is $18.75, with a high forecast of $32.25 and a low forecast of $5.25. The average price target represents a 271.29% upside from the last price of $5.05.
Current Consensus is
Hold
The current consensus among 5 investment analysts is to hold stock in Curaleaf. This Hold consensus rating has held steady for over two years.
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.
Read More